<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31555895</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>138</Volume><Issue>5</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.</ArticleTitle><Pagination><StartPage>751</StartPage><EndPage>770</EndPage><MedlinePgn>751-770</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-019-02077-x</ELocationID><Abstract><AbstractText>Transactive response DNA-binding protein 43&#xa0;kDa (TDP-43) was identified as a major disease-associated component in the brain of patients with amyotrophic lateral sclerosis (ALS), as well as the largest subset of patients with frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U), which characteristically exhibits cytoplasmic inclusions that are positive for ubiquitin but negative for tau and &#x3b1;-synuclein. TDP-43 pathology occurs in distinct brain regions, involves disparate brain networks, and features accumulation of misfolded proteins in various cell types and in different neuroanatomical regions. The clinical phenotypes of ALS and FTLD-TDP (FTLD with abnormal intracellular accumulations of TDP-43) correlate with characteristic distribution patterns of the underlying pathology across specific brain regions with disease progression. Recent studies support the idea that pathological protein spreads from neuron to neuron via axonal transport in a hierarchical manner. However, little is known to date about the basis of the selective cellular and regional vulnerability, although the information would have important implications for the development of targeted and personalized therapies. Here, we aim to summarize recent advances in the neuropathology, genetics and animal models of TDP-43 proteinopathy, and their relationship to clinical phenotypes for the underlying selective neuronal and regional susceptibilities. Finally, we attempt to integrate these findings into the emerging picture of TDP-43 proteinopathy, and to highlight key issues for future therapy and research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kawakami</LastName><ForeName>Ito</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Dementia Research Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuropathology, Tokyo Metropolitan Geriatric Hospital and Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arai</LastName><ForeName>Tetsuaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Dementia Research Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. 4632tetsu@md.tsukuba.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. 4632tetsu@md.tsukuba.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Masato</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7415-8159</Identifier><AffiliationInfo><Affiliation>Dementia Research Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6, Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. hasegawa-ms@igakuken.or.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP26117005</GrantID><Agency>Ministry of Education, Culture, Sports, Science, and Technology Grants-in-Aid for Scientific Research Grants</Agency><Country>International</Country></Grant><Grant><GrantID>JP23228004</GrantID><Agency>Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant</Agency><Country>International</Country></Grant><Grant><GrantID>JP14533254</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="N">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="N">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FTLD</Keyword><Keyword MajorTopicYN="N">Progression</Keyword><Keyword MajorTopicYN="N">Proteinopathy</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">Vulnerability</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31555895</ArticleId><ArticleId IdType="pmc">PMC6800885</ArticleId><ArticleId IdType="doi">10.1007/s00401-019-02077-x</ArticleId><ArticleId IdType="pii">10.1007/s00401-019-02077-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agosta F, Canu E, Valsasina P, Riva N, Prelle A, Comi G, et al. Divergent brain network connectivity in amyotrophic lateral sclerosis. Neurobiol Aging. 2013;34:419&#x2013;427. doi: 10.1016/j.neurobiolaging.2012.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.04.015</ArticleId><ArticleId IdType="pubmed">22608240</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SSW, et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81:536&#x2013;543. doi: 10.1016/j.neuron.2013.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson EN, Gochenaur L, Singh A, Grant R, Patel K, Watkins S, et al. Traumatic injury induces stress granule formation and enhances motor dysfunctions in ALS/FTD models. Hum Mol Genet. 2018;27:1366&#x2013;1381. doi: 10.1093/hmg/ddy047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy047</ArticleId><ArticleId IdType="pmc">PMC6455923</ArticleId><ArticleId IdType="pubmed">29432563</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T. Significance and limitation of the pathological classification of TDP-43 proteinopathy. Neuropathology. 2014;34:578&#x2013;588. doi: 10.1111/neup.12138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12138</ArticleId><ArticleId IdType="pubmed">25196969</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Nonoka T, Kametani F, Yamashita M, Hosokawa M, et al. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology. 2010;30:170&#x2013;181. doi: 10.1111/j.1440-1789.2009.01089.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2009.01089.x</ArticleId><ArticleId IdType="pubmed">20102522</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K, et al. Phosphorylated TDP-43 in Alzheimer&#x2019;s disease and dementia with Lewy bodies. Acta Neuropathol. 2009;117:125&#x2013;136. doi: 10.1007/s00401-008-0480-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0480-1</ArticleId><ArticleId IdType="pubmed">19139911</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Nonaka T, Hasegawa M, Akiyama H, Yoshida M, Hashizume Y, et al. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci Lett. 2003;342:41&#x2013;44. doi: 10.1016/S0304-3940(03)00216-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(03)00216-7</ArticleId><ArticleId IdType="pubmed">12727313</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold ES, Ling SC, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci USA. 2013;110:E736&#x2013;745. doi: 10.1073/pnas.1222809110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold SJ, Dugger BN, Beach TG. TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies. Acta Neuropathol. 2013;126:51&#x2013;57. doi: 10.1007/s00401-013-1110-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1110-0</ArticleId><ArticleId IdType="pmc">PMC3691299</ArticleId><ArticleId IdType="pubmed">23604587</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A, Vande Velde C. Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS? Front Cell Neurosci. 2015;9:423. doi: 10.3389/fncel.2015.00423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00423</ArticleId><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin JA, Wright GS, Watanabe S, Grossmann JG, Antonyuk SV, Yamanaka K, et al. Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life. Proc Natl Acad Sci USA. 2014;111:4309&#x2013;4314. doi: 10.1073/pnas.1317317111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1317317111</ArticleId><ArticleId IdType="pmc">PMC3964094</ArticleId><ArticleId IdType="pubmed">24591609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, De Conti L, Avendano-Vazquez SE, Dhir A, Romano M, D&#x2019;Ambrogio A, et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2011;30:277&#x2013;288. doi: 10.1038/emboj.2010.310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.310</ArticleId><ArticleId IdType="pmc">PMC3025456</ArticleId><ArticleId IdType="pubmed">21131904</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916&#x2013;919. doi: 10.1038/nature05016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05016</ArticleId><ArticleId IdType="pubmed">16862116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137:2329&#x2013;2345. doi: 10.1093/brain/awu138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, Serio A, Arjun A, Bilican B, Daub A, Ando DM, et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat Chem Biol. 2014;10:677&#x2013;685. doi: 10.1038/nchembio.1563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1563</ArticleId><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Bathgate D, Snowden JS, Varma A, Blackshaw A, Neary D. Behaviour in frontotemporal dementia, Alzheimer&#x2019;s disease and vascular dementia. Acta Neurol Scand. 2001;103:367&#x2013;378. doi: 10.1034/j.1600-0404.2001.2000236.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0404.2001.2000236.x</ArticleId><ArticleId IdType="pubmed">11421849</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Bokde AL, Byrne S, Elamin M, McLaughlin RL, Kenna K, et al. Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology. 2013;81:361&#x2013;369. doi: 10.1212/WNL.0b013e31829c5eee.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31829c5eee</ArticleId><ArticleId IdType="pmc">PMC3772833</ArticleId><ArticleId IdType="pubmed">23771489</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Hardiman O. Lessons of ALS imaging: pitfalls and future directions&#x2014;a critical review. Neuroimage Clin. 2014;4:436&#x2013;443. doi: 10.1016/j.nicl.2014.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2014.02.011</ArticleId><ArticleId IdType="pmc">PMC3950559</ArticleId><ArticleId IdType="pubmed">24624329</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A, Padovani A, Borroni B. Phenotypic heterogeneity of monogenic frontotemporal dementia. Front Aging Neurosci. 2015;7:171. doi: 10.3389/fnagi.2015.00171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00171</ArticleId><ArticleId IdType="pmc">PMC4555036</ArticleId><ArticleId IdType="pubmed">26388768</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigio EH, Wu JY, Deng HX, Bit-Ivan EN, Mao Q, Ganti R, et al. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Acta Neuropathol. 2013;125:463&#x2013;465. doi: 10.1007/s00401-013-1089-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1089-6</ArticleId><ArticleId IdType="pmc">PMC3593646</ArticleId><ArticleId IdType="pubmed">23378033</ArticleId></ArticleIdList></Reference><Reference><Citation>Boxer AL, Mackenzie IR, Boeve BF, Baker M, Seeley WW, Crook R, et al. Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry. 2011;82:196&#x2013;203. doi: 10.1136/jnnp.2009.204081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.204081</ArticleId><ArticleId IdType="pmc">PMC3017222</ArticleId><ArticleId IdType="pubmed">20562461</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Ludolph A, Thal DR, Del Tredici K. Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord. Acta Neuropathol. 2010;120:67&#x2013;74. doi: 10.1007/s00401-010-0683-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0683-0</ArticleId><ArticleId IdType="pubmed">20379728</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Ludolph AC, Neumann M, Ravits J, Del Tredici K. Pathological TDP-43 changes in Betz cells differ from those in bulbar and spinal alpha-motoneurons in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:79&#x2013;90. doi: 10.1007/s00401-016-1633-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1633-2</ArticleId><ArticleId IdType="pmc">PMC5209403</ArticleId><ArticleId IdType="pubmed">27757524</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Irwin DJ, Grossman M, Robinson JL, Toledo JB, et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD) Acta Neuropathol. 2014;127:423&#x2013;439. doi: 10.1007/s00401-013-1238-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1238-y</ArticleId><ArticleId IdType="pmc">PMC3971993</ArticleId><ArticleId IdType="pubmed">24407427</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunello CA, Yan X, Huttunen HJ. Internalized Tau sensitizes cells to stress by promoting formation and stability of stress granules. Sci Rep. 2016;6:30498. doi: 10.1038/srep30498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep30498</ArticleId><ArticleId IdType="pmc">PMC4962319</ArticleId><ArticleId IdType="pubmed">27460788</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan JR, Muhlrad D, Parker R. P bodies promote stress granule assembly in Saccharomyces cerevisiae. J Cell Biol. 2008;183:441&#x2013;455. doi: 10.1083/jcb.200807043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200807043</ArticleId><ArticleId IdType="pmc">PMC2575786</ArticleId><ArticleId IdType="pubmed">18981231</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, De Conti L, Stuani C, Romano M, Baralle M, Baralle F. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 2010;277:2268&#x2013;2281. doi: 10.1111/j.1742-4658.2010.07643.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2010.07643.x</ArticleId><ArticleId IdType="pubmed">20423455</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Dork T, Zuccato E, Pagani F, Romano M, Baralle FE. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 2001;20:1774&#x2013;1784. doi: 10.1093/emboj/20.7.1774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.7.1774</ArticleId><ArticleId IdType="pmc">PMC145463</ArticleId><ArticleId IdType="pubmed">11285240</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, Halliday GM, Kril JJ, Ittner LM, Gotz J, Kiernan MC, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388:919&#x2013;931. doi: 10.1016/S0140-6736(16)00737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00737-6</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, Kiernan MC, Vucic S, Hodges JR. Motor neuron dysfunction in frontotemporal dementia. Brain. 2011;134:2582&#x2013;2594. doi: 10.1093/brain/awr195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr195</ArticleId><ArticleId IdType="pubmed">21840887</ArticleId></ArticleIdList></Reference><Reference><Citation>Bury JJ, Highley JR, Cooper-Knock J, Goodall EF, Higginbottom A, McDermott CJ, et al. Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72-ALS. Neuropathology. 2016;36:125&#x2013;134. doi: 10.1111/neup.12240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12240</ArticleId><ArticleId IdType="pubmed">26303227</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol. 2007;171:227&#x2013;240. doi: 10.2353/ajpath.2007.070182.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2007.070182</ArticleId><ArticleId IdType="pmc">PMC1941578</ArticleId><ArticleId IdType="pubmed">17591968</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, Zhang Y, Umoh ME, Vaughan SW, Lorenzini I, Liu F, et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Cistaro A, Pagani M, Montuschi A, Calvo A, Moglia C, Canosa A, et al. The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging. 2014;41:844&#x2013;852. doi: 10.1007/s00259-013-2667-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-013-2667-5</ArticleId><ArticleId IdType="pubmed">24445987</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerc P, Lipnick S, Willett C. A look into the future of ALS research. Drug Discov Today. 2016;21:939&#x2013;949. doi: 10.1016/j.drudis.2016.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2016.02.002</ArticleId><ArticleId IdType="pubmed">26861067</ArticleId></ArticleIdList></Reference><Reference><Citation>Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of &#x2018;new variant&#x2019; CJD. Nature. 1996;383:685&#x2013;690. doi: 10.1038/383685a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/383685a0</ArticleId><ArticleId IdType="pubmed">8878476</ArticleId></ArticleIdList></Reference><Reference><Citation>Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128:755&#x2013;766. doi: 10.1007/s00401-014-1349-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1349-0</ArticleId><ArticleId IdType="pmc">PMC4257842</ArticleId><ArticleId IdType="pubmed">25348064</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920&#x2013;924. doi: 10.1038/nature05017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05017</ArticleId><ArticleId IdType="pubmed">16862115</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Alton S, Altshuler M, Cannon A, Dickson DW, Petrucelli L, Lewis J. Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling. PLoS One. 2014;9:e86513. doi: 10.1371/journal.pone.0086513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0086513</ArticleId><ArticleId IdType="pmc">PMC3899264</ArticleId><ArticleId IdType="pubmed">24466128</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown S, Du Plessis D, Neary D, et al. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol. 2007;113:521&#x2013;533. doi: 10.1007/s00401-006-0189-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-006-0189-y</ArticleId><ArticleId IdType="pubmed">17219193</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney E, Hornberger M, Irish M, Mioshi E, Burrell J, Tan R, et al. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol. 2014;71:331&#x2013;339. doi: 10.1001/jamaneurol.2013.6002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.6002</ArticleId><ArticleId IdType="pubmed">24445580</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, Weller RO, editors. Neurodegeneration: the molecular pathology of dementia and movement disorders. 2. London: Wiley and Blackwell; 2011.</Citation></Reference><Reference><Citation>Falcon B, Zhang W, Murzin AG, Murshudov G, Garringer HJ, Vidal R, et al. Structures of filaments from Pick&#x2019;s disease reveal a novel tau protein fold. Nature. 2018;561:137&#x2013;140. doi: 10.1038/s41586-018-0454-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0454-y</ArticleId><ArticleId IdType="pmc">PMC6204212</ArticleId><ArticleId IdType="pubmed">30158706</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang YS, Tsai KJ, Chang YJ, Kao P, Woods R, Kuo PH, et al. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients. Nat Commun. 2014;5:4824. doi: 10.1038/ncomms5824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5824</ArticleId><ArticleId IdType="pubmed">25215604</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler MS, Strobel B, Freischmidt A, Helferich AM, Kappel J, Brewer BM, et al. TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol. 2015;211:897&#x2013;911. doi: 10.1083/jcb.201504057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Fekete T, Zach N, Mujica-Parodi LR, Turner MR. Multiple kernel learning captures a systems-level functional connectivity biomarker signature in amyotrophic lateral sclerosis. PLoS One. 2013;8:e85190. doi: 10.1371/journal.pone.0085190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0085190</ArticleId><ArticleId IdType="pmc">PMC3877396</ArticleId><ArticleId IdType="pubmed">24391997</ArticleId></ArticleIdList></Reference><Reference><Citation>Foulds P, McAuley E, Gibbons L, Davidson Y, Pickering-Brown SM, Neary D, et al. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer&#x2019;s disease and frontotemporal lobar degeneration. Acta Neuropathol. 2008;116:141&#x2013;146. doi: 10.1007/s00401-008-0389-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0389-8</ArticleId><ArticleId IdType="pmc">PMC2464623</ArticleId><ArticleId IdType="pubmed">18506455</ArticleId></ArticleIdList></Reference><Reference><Citation>Foulds PG, Davidson Y, Mishra M, Hobson DJ, Humphreys KM, Taylor M, et al. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol. 2009;118:647&#x2013;658. doi: 10.1007/s00401-009-0594-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0594-0</ArticleId><ArticleId IdType="pmc">PMC2809136</ArticleId><ArticleId IdType="pubmed">19823856</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P, Sivakumar P, Humphrey J, Lo K, Ricketts T, Oliveira H, et al. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO J. 2018 doi: 10.15252/embj.201798684.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798684</ArticleId><ArticleId IdType="pmc">PMC5983119</ArticleId><ArticleId IdType="pubmed">29764981</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, Muller K, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujishiro H, Uchikado H, Arai T, Hasegawa M, Akiyama H, Yokota O, et al. Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease. Acta Neuropathol. 2009;117:151&#x2013;158. doi: 10.1007/s00401-008-0463-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0463-2</ArticleId><ArticleId IdType="pubmed">19039597</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F, Lu S, Yu H, Chen C, Melamed Z, Guo L, et al. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron. 2019;102(339&#x2013;357):e337. doi: 10.1016/j.neuron.2019.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.038</ArticleId><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M, Jara JH, Kocak N, Rylaarsdam LE, Kim KD, et al. Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology. Acta Neuropathol. 2019;137:47&#x2013;69. doi: 10.1007/s00401-018-1934-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1934-8</ArticleId><ArticleId IdType="pmc">PMC6339587</ArticleId><ArticleId IdType="pubmed">30450515</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F, Brandmeir NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol. 2008;65:636&#x2013;641. doi: 10.1001/archneur.65.5.636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.5.636</ArticleId><ArticleId IdType="pubmed">18474740</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F, Martinez-Lage M, Kwong LK, Lee VM, Trojanowski JQ. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J Neurol. 2009;256:1205&#x2013;1214. doi: 10.1007/s00415-009-5069-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5069-7</ArticleId><ArticleId IdType="pmc">PMC2790321</ArticleId><ArticleId IdType="pubmed">19271105</ArticleId></ArticleIdList></Reference><Reference><Citation>Goossens J, Vanmechelen E, Trojanowski JQ, Lee VM, Van Broeckhoven C, van der Zee J, et al. TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies. Acta Neuropathol Commun. 2015;3:15. doi: 10.1186/s40478-015-0195-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0195-1</ArticleId><ArticleId IdType="pmc">PMC4380254</ArticleId><ArticleId IdType="pubmed">25853864</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55:335&#x2013;346. doi: 10.1002/ana.10825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10825</ArticleId><ArticleId IdType="pmc">PMC2362399</ArticleId><ArticleId IdType="pubmed">14991811</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006&#x2013;1014. doi: 10.1212/WNL.0b013e31821103e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821103e6</ArticleId><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosskreutz J, Van Den Bosch L, Keller BU. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium. 2010;47:165&#x2013;174. doi: 10.1016/j.ceca.2009.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2009.12.002</ArticleId><ArticleId IdType="pubmed">20116097</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy J, Rogaeva E. Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not. Exp Neurol. 2014;262(Pt B):75&#x2013;83. doi: 10.1016/j.expneurol.2013.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.11.006</ArticleId><ArticleId IdType="pubmed">24246281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Akiyama H, Nonaka T, Mori H, Hashimoto T, et al. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain. 2007;130:1386&#x2013;1394. doi: 10.1093/brain/awm065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm065</ArticleId><ArticleId IdType="pubmed">17439983</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol. 2008;64:60&#x2013;70. doi: 10.1002/ana.21425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21425</ArticleId><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, et al. Significance of the TDP-43 deposition in FTLD-U and ALS. Rinsho Shinkeigaku. 2008;48:994&#x2013;997. doi: 10.5692/clinicalneurol.48.994.</Citation><ArticleIdList><ArticleId IdType="doi">10.5692/clinicalneurol.48.994</ArticleId><ArticleId IdType="pubmed">19198142</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Nonaka T, Masuda-Suzukake M. Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders. Pharmacol Ther. 2017;172:22&#x2013;33. doi: 10.1016/j.pharmthera.2016.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2016.11.010</ArticleId><ArticleId IdType="pubmed">27916654</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatanpaa KJ, Bigio EH, Cairns NJ, Womack KB, Weintraub S, Morris JC, et al. TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study. J Neuropathol Exp Neurol. 2008;67:271&#x2013;279. doi: 10.1097/NEN.0b013e31816a12a6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31816a12a6</ArticleId><ArticleId IdType="pmc">PMC2635119</ArticleId><ArticleId IdType="pubmed">18379440</ArticleId></ArticleIdList></Reference><Reference><Citation>Homan P, Levy I, Feltham E, Gordon C, Hu J, Li J, et al. Neural computations of threat in the aftermath of combat trauma. Nat Neurosci. 2019;22:470&#x2013;476. doi: 10.1038/s41593-018-0315-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0315-x</ArticleId><ArticleId IdType="pmc">PMC6829910</ArticleId><ArticleId IdType="pubmed">30664770</ArticleId></ArticleIdList></Reference><Reference><Citation>Huey ED, Goveia EN, Paviol S, Pardini M, Krueger F, Zamboni G, et al. Executive dysfunction in frontotemporal dementia and corticobasal syndrome. Neurology. 2009;72:453&#x2013;459. doi: 10.1212/01.wnl.0000341781.39164.26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000341781.39164.26</ArticleId><ArticleId IdType="pmc">PMC2677529</ArticleId><ArticleId IdType="pubmed">19188577</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y, et al. Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain. 2016;139:3187&#x2013;3201. doi: 10.1093/brain/aww237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww237</ArticleId><ArticleId IdType="pmc">PMC5840881</ArticleId><ArticleId IdType="pubmed">27679482</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, McMillan CT, Brettschneider J, Libon DJ, Powers J, et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84:163&#x2013;169. doi: 10.1136/jnnp-2012-303507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303507</ArticleId><ArticleId IdType="pmc">PMC3543474</ArticleId><ArticleId IdType="pubmed">23117491</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson M, Lennox G, Lowe J. Motor neurone disease-inclusion dementia. Neurodegeneration. 1996;5:339&#x2013;350. doi: 10.1006/neur.1996.0046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/neur.1996.0046</ArticleId><ArticleId IdType="pubmed">9117546</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji AL, Zhang X, Chen WW, Huang WJ. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum. J Med Genet. 2017;54:145&#x2013;154. doi: 10.1136/jmedgenet-2016-104271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2016-104271</ArticleId><ArticleId IdType="pubmed">28087719</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122:137&#x2013;153. doi: 10.1007/s00401-011-0839-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0839-6</ArticleId><ArticleId IdType="pmc">PMC3232515</ArticleId><ArticleId IdType="pubmed">21614463</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Mackenzie I, Frosch MP, Bigio EH, Neumann M, Arai T, et al. LATE to the PART-y. Brain. 2019 doi: 10.1093/brain/awz224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz224</ArticleId><ArticleId IdType="pmc">PMC6736234</ArticleId><ArticleId IdType="pubmed">31359030</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Murray ME, Tosakulwong N, Weigand SD, Knopman DS, Petersen RC, et al. Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43&#xa0;kDa. Alzheimers Dement. 2019;15:799&#x2013;806. doi: 10.1016/j.jalz.2019.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.03.003</ArticleId><ArticleId IdType="pmc">PMC6556401</ArticleId><ArticleId IdType="pubmed">31056344</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Murray ME, Tosakulwong N, Weigand SD, Serie AM, Perkerson RB, et al. Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains. Acta Neuropathol. 2019;137:227&#x2013;238. doi: 10.1007/s00401-018-1951-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1951-7</ArticleId><ArticleId IdType="pmc">PMC6358471</ArticleId><ArticleId IdType="pubmed">30604226</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Murray ME, Whitwell JL, Tosakulwong N, Weigand SD, Petrucelli L, et al. Updated TDP-43 in Alzheimer&#x2019;s disease staging scheme. Acta Neuropathol. 2016;131:571&#x2013;585. doi: 10.1007/s00401-016-1537-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1537-1</ArticleId><ArticleId IdType="pmc">PMC5946692</ArticleId><ArticleId IdType="pubmed">26810071</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM, et al. TDP-43 is a key player in the clinical features associated with Alzheimer&#x2019;s disease. Acta Neuropathol. 2014;127:811&#x2013;824. doi: 10.1007/s00401-014-1269-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1269-z</ArticleId><ArticleId IdType="pmc">PMC4172544</ArticleId><ArticleId IdType="pubmed">24659241</ArticleId></ArticleIdList></Reference><Reference><Citation>Junttila A, Kuvaja M, Hartikainen P, Siloaho M, Helisalmi S, Moilanen V, et al. Cerebrospinal fluid TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis patients with and without the C9ORF72 hexanucleotide expansion. Dement Geriatr Cogn Dis Extra. 2016;6:142&#x2013;149. doi: 10.1159/000444788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000444788</ArticleId><ArticleId IdType="pmc">PMC4868946</ArticleId><ArticleId IdType="pubmed">27195002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F, Obi T, Shishido T, Akatsu H, Murayama S, Saito Y, et al. Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci Rep. 2016;6:23281. doi: 10.1038/srep23281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23281</ArticleId><ArticleId IdType="pmc">PMC4793195</ArticleId><ArticleId IdType="pubmed">26980269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K, Martinez FJ, Yeo GW. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum Genet. 2017;136:1193&#x2013;1214. doi: 10.1007/s00439-017-1830-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1830-7</ArticleId><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim EJ, Sidhu M, Gaus SE, Huang EJ, Hof PR, Miller BL, et al. Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia. Cereb Cortex. 2016;26:1843. doi: 10.1093/cercor/bhw012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhw012</ArticleId><ArticleId IdType="pmc">PMC6272814</ArticleId><ArticleId IdType="pubmed">26796215</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs GG. Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine. Int J Mol Sci. 2016 doi: 10.3390/ijms17020189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17020189</ArticleId><ArticleId IdType="pmc">PMC4783923</ArticleId><ArticleId IdType="pubmed">26848654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs GG, Botond G, Budka H. Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics. Acta Neuropathol. 2010;119:389&#x2013;408. doi: 10.1007/s00401-010-0658-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0658-1</ArticleId><ArticleId IdType="pubmed">20198481</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs GG, Murrell JR, Horvath S, Haraszti L, Majtenyi K, Molnar MJ, et al. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord. 2009;24:1843&#x2013;1847. doi: 10.1002/mds.22697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22697</ArticleId><ArticleId IdType="pubmed">19609911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuiperij HB, Abdo WF, van Engelen BG, Schelhaas HJ, Verbeek MM. TDP-43 plasma levels do not differentiate sporadic inclusion body myositis from other inflammatory myopathies. Acta Neuropathol. 2010;120:825&#x2013;826. doi: 10.1007/s00401-010-0769-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0769-8</ArticleId><ArticleId IdType="pubmed">21046407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo PH, Doudeva LG, Wang YT, Shen CK, Yuan HS. Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res. 2009;37:1799&#x2013;1808. doi: 10.1093/nar/gkp013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp013</ArticleId><ArticleId IdType="pmc">PMC2665213</ArticleId><ArticleId IdType="pubmed">19174564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet. 2010;19:R46&#x2013;64. doi: 10.1093/hmg/ddq137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq137</ArticleId><ArticleId IdType="pmc">PMC3167692</ArticleId><ArticleId IdType="pubmed">20400460</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK, et al. Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol. 2017;134:65&#x2013;78. doi: 10.1007/s00401-017-1679-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1679-9</ArticleId><ArticleId IdType="pmc">PMC5521959</ArticleId><ArticleId IdType="pubmed">28130640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SE, Khazenzon AM, Trujillo AJ, Guo CC, Yokoyama JS, Sha SJ, et al. Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. Brain. 2014;137:3047&#x2013;3060. doi: 10.1093/brain/awu248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu248</ArticleId><ArticleId IdType="pmc">PMC4208465</ArticleId><ArticleId IdType="pubmed">25273996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Garcin B, Hornberger M, Bak TH, Hodges JR. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol. 2010;67:826&#x2013;830. doi: 10.1001/archneurol.2010.146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.146</ArticleId><ArticleId IdType="pubmed">20625088</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59:1077&#x2013;1079. doi: 10.1212/WNL.59.7.1077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.59.7.1077</ArticleId><ArticleId IdType="pubmed">12370467</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61:427&#x2013;434. doi: 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Frick P, Neumann M. The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol. 2014;127:347&#x2013;357. doi: 10.1007/s00401-013-1232-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1232-4</ArticleId><ArticleId IdType="pubmed">24356984</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122:111&#x2013;113. doi: 10.1007/s00401-011-0845-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0845-8</ArticleId><ArticleId IdType="pmc">PMC3285143</ArticleId><ArticleId IdType="pubmed">21644037</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol. 2009;117:15&#x2013;18. doi: 10.1007/s00401-008-0460-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0460-5</ArticleId><ArticleId IdType="pmc">PMC2710877</ArticleId><ArticleId IdType="pubmed">19015862</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Nicholson AM, Sarkar M, Messing J, Purice MD, Pottier C, et al. TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron. 2017;95(808&#x2013;816):e809. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain. 2012;135:736&#x2013;750. doi: 10.1093/brain/awr361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr361</ArticleId><ArticleId IdType="pmc">PMC3286330</ArticleId><ArticleId IdType="pubmed">22366791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis-Marks MR, Needham PG, et al. RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron. 2019;102(321&#x2013;338):e328. doi: 10.1016/j.neuron.2019.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, et al. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016;131:75&#x2013;86. doi: 10.1007/s00401-015-1515-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1515-z</ArticleId><ArticleId IdType="pmc">PMC4698281</ArticleId><ArticleId IdType="pubmed">26667418</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Gavett BE, Stern RA, Nowinski CJ, Cantu RC, Kowall NW, et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol. 2010;69:918&#x2013;929. doi: 10.1097/NEN.0b013e3181ee7d85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181ee7d85</ArticleId><ArticleId IdType="pmc">PMC2951281</ArticleId><ArticleId IdType="pubmed">20720505</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Robinson ME. Military-related traumatic brain injury and neurodegeneration. Alzheimers Dement. 2014;10:S242&#x2013;253. doi: 10.1016/j.jalz.2014.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.04.003</ArticleId><ArticleId IdType="pmc">PMC4255273</ArticleId><ArticleId IdType="pubmed">24924675</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013;136:43&#x2013;64. doi: 10.1093/brain/aws307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws307</ArticleId><ArticleId IdType="pmc">PMC3624697</ArticleId><ArticleId IdType="pubmed">23208308</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer H, Weihl CC. The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. J Cell Sci. 2014;127:3877&#x2013;3883. doi: 10.1242/jcs.093831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.093831</ArticleId><ArticleId IdType="pmc">PMC4163641</ArticleId><ArticleId IdType="pubmed">25146396</ArticleId></ArticleIdList></Reference><Reference><Citation>Nana AL, Sidhu M, Gaus SE, Hwang JL, Li L, Park Y, et al. Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology. Acta Neuropathol. 2019;137:27&#x2013;46. doi: 10.1007/s00401-018-1942-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1942-8</ArticleId><ArticleId IdType="pmc">PMC6339592</ArticleId><ArticleId IdType="pubmed">30511086</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142:1503&#x2013;1527. doi: 10.1093/brain/awz099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz099</ArticleId><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Schmitt FA, Lin Y, Abner EL, Jicha GA, Patel E, et al. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain. 2011;134:1506&#x2013;1518. doi: 10.1093/brain/awr053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr053</ArticleId><ArticleId IdType="pmc">PMC3097889</ArticleId><ArticleId IdType="pubmed">21596774</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Sampathu DM, Trojanowski JQ, Lee VM. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch Neurol. 2007;64:1388&#x2013;1394. doi: 10.1001/archneur.64.10.1388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.10.1388</ArticleId><ArticleId IdType="pubmed">17923623</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Truax AC, Vanmassenhove B, Kretzschmar HA, et al. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol. 2007;66:177&#x2013;183. doi: 10.1097/01.jnen.0000248554.45456.58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000248554.45456.58</ArticleId><ArticleId IdType="pubmed">17356379</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T, et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013;4:124&#x2013;134. doi: 10.1016/j.celrep.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto K, Fujita Y, Mizuno Y. Pathology of protein synthesis and degradation systems in ALS. Neuropathology. 2010;30:189&#x2013;193. doi: 10.1111/j.1440-1789.2009.01088.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2009.01088.x</ArticleId><ArticleId IdType="pubmed">20102523</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou SH, Wu F, Harrich D, Garcia-Martinez LF, Gaynor RB. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol. 1995;69:3584&#x2013;3596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp N, et al. Typing prion isoforms. Nature. 1997;386:232&#x2013;234. doi: 10.1038/386232a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/386232a0</ArticleId><ArticleId IdType="pubmed">9069279</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters F, Perani D, Herholz K, Holthoff V, Beuthien-Baumann B, Sorbi S, et al. Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord. 2006;21:373&#x2013;379. doi: 10.1159/000091898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000091898</ArticleId><ArticleId IdType="pubmed">16534207</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S, Xu Y, Restrepo CR, Kwong LK, Zhang B, Brown HJ, et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun. 2018;9:4220. doi: 10.1038/s41467-018-06548-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06548-9</ArticleId><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456&#x2013;2477. doi: 10.1093/brain/awr179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Riggs JE. The latency between traumatic axonal injury and the onset of amyotrophic lateral sclerosis in young adult men. Mil Med. 2001;166:731&#x2013;732. doi: 10.1093/milmed/166.8.731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/milmed/166.8.731</ArticleId><ArticleId IdType="pubmed">11515328</ArticleId></ArticleIdList></Reference><Reference><Citation>Riggs JE, Hobbs GR. Motor axonal injury and amyotrophic lateral sclerosis: risk assessment using a reverse probability analysis technique. Mil Med. 2003;168:143&#x2013;145. doi: 10.1093/milmed/168.2.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/milmed/168.2.143</ArticleId><ArticleId IdType="pubmed">12636144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586&#x2013;590. doi: 10.1212/01.wnl.0000172911.39167.b6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000172911.39167.b6</ArticleId><ArticleId IdType="pubmed">16116120</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364:362. doi: 10.1038/364362c0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/364362c0</ArticleId><ArticleId IdType="pubmed">8332197</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholl M, Damian A, Engler H. Fluorodeoxyglucose PET in neurology and psychiatry. PET Clin. 2014;9(371&#x2013;390):v. doi: 10.1016/j.cpet.2014.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpet.2014.07.005</ArticleId><ArticleId IdType="pubmed">26050943</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab C, Arai T, Hasegawa M, Akiyama H, Yu S, McGeer PL. TDP-43 pathology in familial British dementia. Acta Neuropathol. 2009;118:303&#x2013;311. doi: 10.1007/s00401-009-0514-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0514-3</ArticleId><ArticleId IdType="pubmed">19283396</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry. 2011;82:476&#x2013;486. doi: 10.1136/jnnp.2010.212225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.212225</ArticleId><ArticleId IdType="pubmed">20971753</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative diseases target large-scale human brain networks. Neuron. 2009;62:42&#x2013;52. doi: 10.1016/j.neuron.2009.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2009.03.024</ArticleId><ArticleId IdType="pmc">PMC2691647</ArticleId><ArticleId IdType="pubmed">19376066</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha SJ, Takada LT, Rankin KP, Yokoyama JS, Rutherford NJ, Fong JC, et al. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology. 2012;79:1002&#x2013;1011. doi: 10.1212/WNL.0b013e318268452e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318268452e</ArticleId><ArticleId IdType="pmc">PMC3430713</ArticleId><ArticleId IdType="pubmed">22875087</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw PJ, Eggett CJ. Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol. 2000;247(Suppl 1):I17&#x2013;27. doi: 10.1007/BF03161151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03161151</ArticleId><ArticleId IdType="pubmed">10795883</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimonaka S, Nonaka T, Suzuki G, Hisanaga S, Hasegawa M. Templated aggregation of TAR DNA-binding protein of 43&#xa0;kDa (TDP-43) by seeding with TDP-43 peptide fibrils. J Biol Chem. 2016;291:8896&#x2013;8907. doi: 10.1074/jbc.M115.713552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.713552</ArticleId><ArticleId IdType="pmc">PMC4861459</ArticleId><ArticleId IdType="pubmed">26887947</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimozawa A, Ono M, Takahara D, Tarutani A, Imura S, Masuda-Suzukake M, et al. Propagation of pathological alpha-synuclein in marmoset brain. Acta Neuropathol Commun. 2017;5:12. doi: 10.1186/s40478-017-0413-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0413-0</ArticleId><ArticleId IdType="pmc">PMC5289012</ArticleId><ArticleId IdType="pubmed">28148299</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden J, Neary D, Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 2007;114:31&#x2013;38. doi: 10.1007/s00401-007-0236-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0236-3</ArticleId><ArticleId IdType="pubmed">17569065</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain. 2012;135:693&#x2013;708. doi: 10.1093/brain/awr355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr355</ArticleId><ArticleId IdType="pmc">PMC3286329</ArticleId><ArticleId IdType="pubmed">22300873</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Restrepo CR, Khan T, Dominique MA, Fang TC, Canter RG, et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat Neurosci. 2018;21:329&#x2013;340. doi: 10.1038/s41593-018-0083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P, Barschke P, Otto M. Biomarkers for diseases with TDP-43 pathology. Mol Cell Neurosci. 2018 doi: 10.1016/j.mcn.2018.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2018.10.003</ArticleId><ArticleId IdType="pubmed">30399416</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P, Hendrich C, Sperfeld AD, Jesse S, von Arnim CA, Lehnert S, et al. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol. 2008;65:1481&#x2013;1487. doi: 10.1001/archneur.65.11.1481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.11.1481</ArticleId><ArticleId IdType="pmc">PMC2690860</ArticleId><ArticleId IdType="pubmed">19001167</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot K. Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability? J Anat. 2014;224:45&#x2013;51. doi: 10.1111/joa.12107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joa.12107</ArticleId><ArticleId IdType="pmc">PMC3867886</ArticleId><ArticleId IdType="pubmed">24010870</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CF, Eguchi H, Tagawa A, Onodera O, Iwasaki T, Tsujino A, et al. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol. 2007;113:535&#x2013;542. doi: 10.1007/s00401-007-0206-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0206-9</ArticleId><ArticleId IdType="pubmed">17333220</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y, Chambers JK, Matsuwaki T, Yamanouchi K, Nishihara M. Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice. Acta Neuropathol Commun. 2014;2:78. doi: 10.1186/s40478-014-0078-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0078-x</ArticleId><ArticleId IdType="pmc">PMC4149276</ArticleId><ArticleId IdType="pubmed">25022663</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y, Suzuki G, Matsuwaki T, Hosokawa M, Serrano G, Beach TG, et al. Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes. Hum Mol Genet. 2017;26:969&#x2013;988. doi: 10.1093/hmg/ddx011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx011</ArticleId><ArticleId IdType="pubmed">28073925</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen GM, Vit JP, Lamb A, Gowing G, Shelest O, Alkaslasi M, et al. Acute traumatic brain injury does not exacerbate amyotrophic lateral sclerosis in the SOD1 (G93A) rat model. eNeuro. 2015 doi: 10.1523/eneuro.0059-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/eneuro.0059-14.2015</ArticleId><ArticleId IdType="pmc">PMC4586929</ArticleId><ArticleId IdType="pubmed">26464984</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji H, Arai T, Kametani F, Nonaka T, Yamashita M, Suzukake M, et al. Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain. 2012;135:3380&#x2013;3391. doi: 10.1093/brain/aws230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws230</ArticleId><ArticleId IdType="pubmed">23035040</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J, Van Langenhove T, Kovacs GG, Dillen L, Deschamps W, Engelborghs S, et al. Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol. 2014;128:397&#x2013;410. doi: 10.1007/s00401-014-1298-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1298-7</ArticleId><ArticleId IdType="pmc">PMC4131163</ArticleId><ArticleId IdType="pubmed">24899140</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mossevelde S, Engelborghs S, van der Zee J, Van Broeckhoven C. Genotype-phenotype links in frontotemporal lobar degeneration. Nat Rev Neurol. 2018;14:363&#x2013;378. doi: 10.1038/s41582-018-0009-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0009-8</ArticleId><ArticleId IdType="pubmed">29777184</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderweyde T, Apicco DJ, Youmans-Kidder K, Ash PEA, Cook C, Lummertz da Rocha E, et al. Interaction of tau with the RNA-binding protein TIA1 regulates tau pathophysiology and toxicity. Cell Rep. 2016;15:1455&#x2013;1466. doi: 10.1016/j.celrep.2016.04.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.04.045</ArticleId><ArticleId IdType="pmc">PMC5325702</ArticleId><ArticleId IdType="pubmed">27160897</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkening K, Leystra-Lantz C, Yang W, Jaffee H, Strong MJ. Tar DNA binding protein of 43&#xa0;kDa (TDP-43), 14&#x2013;3&#x2013;3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS) Brain Res. 2009;1305:168&#x2013;182. doi: 10.1016/j.brainres.2009.09.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.09.105</ArticleId><ArticleId IdType="pubmed">19815002</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Daniels CM, Goldman JE, Trojanowski JQ, Lee VM, Messing A. Astrocytic TDP-43 pathology in Alexander disease. J Neurosci. 2014;34:6448&#x2013;6458. doi: 10.1523/JNEUROSCI.0248-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0248-14.2014</ArticleId><ArticleId IdType="pmc">PMC4012304</ArticleId><ArticleId IdType="pubmed">24806671</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36:377&#x2013;381. doi: 10.1038/ng1332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1332</ArticleId><ArticleId IdType="pubmed">15034582</ArticleId></ArticleIdList></Reference><Reference><Citation>White MA, Kim E, Duffy A, Adalbert R, Phillips BU, Peters OM, et al. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nat Neurosci. 2018;21:552&#x2013;563. doi: 10.1038/s41593-018-0113-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0113-5</ArticleId><ArticleId IdType="pmc">PMC5884423</ArticleId><ArticleId IdType="pubmed">29556029</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M, et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain. 2012;135:794&#x2013;806. doi: 10.1093/brain/aws001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws001</ArticleId><ArticleId IdType="pmc">PMC3286334</ArticleId><ArticleId IdType="pubmed">22366795</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiesner D, Tar L, Linkus B, Chandrasekar A, Olde Heuvel F, Dupuis L, et al. Reversible induction of TDP-43 granules in cortical neurons after traumatic injury. Exp Neurol. 2018;299:15&#x2013;25. doi: 10.1016/j.expneurol.2017.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.09.011</ArticleId><ArticleId IdType="pubmed">28941811</ArticleId></ArticleIdList></Reference><Reference><Citation>Wightman G, Anderson VE, Martin J, Swash M, Anderton BH, Neary D, et al. Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett. 1992;139:269&#x2013;274. doi: 10.1016/0304-3940(92)90569-S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(92)90569-S</ArticleId><ArticleId IdType="pubmed">1376881</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Topp S, Yang S, Smith B, Fifita JA, Warraich ST, et al. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat Commun. 2016;7:11253. doi: 10.1038/ncomms11253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11253</ArticleId><ArticleId IdType="pmc">PMC4835537</ArticleId><ArticleId IdType="pubmed">27080313</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem. 2008;283:13302&#x2013;13309. doi: 10.1074/jbc.M800342200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800342200</ArticleId><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B. The evolution of phase-separated TDP-43 in stress. Neuron. 2019;102:265&#x2013;267. doi: 10.1016/j.neuron.2019.03.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.03.041</ArticleId><ArticleId IdType="pmc">PMC6816464</ArticleId><ArticleId IdType="pubmed">30998893</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley JD, Gorno-Tempini ML, Seeley WW, Rankin K, Lee SS, Matthews BR, et al. Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology. 2007;69:1424&#x2013;1433. doi: 10.1212/01.wnl.0000277461.06713.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000277461.06713.23</ArticleId><ArticleId IdType="pubmed">17909155</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L, De Jager PL, Yang J, Trojanowski JQ, Bennett DA, Schneider JA. The TMEM106B locus and TDP-43 pathology in older persons without FTLD. Neurology. 2015;84:927&#x2013;934. doi: 10.1212/WNL.0000000000001313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001313</ArticleId><ArticleId IdType="pmc">PMC4351662</ArticleId><ArticleId IdType="pubmed">25653292</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamboni G, Huey ED, Krueger F, Nichelli PF, Grafman J. Apathy and disinhibition in frontotemporal dementia: insights into their neural correlates. Neurology. 2008;71:736&#x2013;742. doi: 10.1212/01.wnl.0000324920.96835.95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000324920.96835.95</ArticleId><ArticleId IdType="pmc">PMC2676948</ArticleId><ArticleId IdType="pubmed">18765649</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H, van Swieten JC, Boxer AL, Rohrer JD. Review: fluid biomarkers for frontotemporal dementias. Neuropathol Appl Neurobiol. 2019;45:81&#x2013;87. doi: 10.1111/nan.12530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12530</ArticleId><ArticleId IdType="pubmed">30422329</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Gennatas ED, Kramer JH, Miller BL, Seeley WW. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron. 2012;73:1216&#x2013;1227. doi: 10.1016/j.neuron.2012.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.03.004</ArticleId><ArticleId IdType="pmc">PMC3361461</ArticleId><ArticleId IdType="pubmed">22445348</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Greicius MD, Gennatas ED, Growdon ME, Jang JY, Rabinovici GD, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer&#x2019;s disease. Brain. 2010;133:1352&#x2013;1367. doi: 10.1093/brain/awq075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq075</ArticleId><ArticleId IdType="pmc">PMC2912696</ArticleId><ArticleId IdType="pubmed">20410145</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>